Cosmos Pharmaceuticals is at the forefront of medication adherence management, utilizing innovative technologies to enhance patient engagement and optimize health outcomes. Central to their approach is the FortisKap system, which incorporates a fingerprint scanner for secure access, ensuring that only authorized users can manage medications. This system not only verifies dosages but also records real-time pill quantities and provides alerts and reminders to help patients stay on track with their prescriptions. By offering individualized resources and statistics, Cosmos aims to improve understanding of medication impacts on symptom management and disease progression, ultimately fostering better adherence and reducing the risk of adverse events.

The company's mission emphasizes the importance of leveraging technology to enhance clinical communication and transparency in prescription adherence. Cosmos Pharmaceuticals recognizes that low adherence can significantly increase readmission rates and is committed to redefining how medication adherence data is captured and utilized. Their proactive monitoring and management of patient medications are designed to prevent complications before they escalate, thereby supporting both patients and healthcare systems in achieving better health outcomes.

United States

Cosmos offers a complete medication adherence platform that is enabled by FortisKap, a smart adherence device designed to secure and monitor adherence of patients in real time. Our platform models patient adherence of prescription regimens for any disease state and patient population. Cosmos distinguishes disease states for appropriate customer support and pricing. The patient centric support and education tools enable each user to have a sense of control and influence over their treatment plan and well being.

Cosmos Pharmaceuticals

Company Details